198 related articles for article (PubMed ID: 10751257)
1. Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barré syndrome.
Ang CW; Jacobs BC; Brandenburg AH; Laman JD; van der Meché FG; Osterhaus AD; van Doorn PA
Neurology; 2000 Apr; 54(7):1453-8. PubMed ID: 10751257
[TBL] [Abstract][Full Text] [Related]
2. [Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis].
Shimoya K; Ohnishi A; Hashimoto T; Yuki N
Rinsho Shinkeigaku; 1997 Feb; 37(2):106-10. PubMed ID: 9164140
[TBL] [Abstract][Full Text] [Related]
3. Association of anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection.
Irie S; Saito T; Nakamura K; Kanazawa N; Ogino M; Nukazawa T; Ito H; Tamai Y; Kowa H
J Neuroimmunol; 1996 Aug; 68(1-2):19-26. PubMed ID: 8784256
[TBL] [Abstract][Full Text] [Related]
4. Antiganglioside antibodies in Guillain-Barré syndrome after a recent cytomegalovirus infection.
Khalili-Shirazi A; Gregson N; Gray I; Rees J; Winer J; Hughes R
J Neurol Neurosurg Psychiatry; 1999 Mar; 66(3):376-9. PubMed ID: 10084538
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barré syndrome.
Jacobs BC; van Doorn PA; Groeneveld JH; Tio-Gillen AP; van der Meché FG
J Neurol Neurosurg Psychiatry; 1997 Jun; 62(6):641-3. PubMed ID: 9219756
[TBL] [Abstract][Full Text] [Related]
6. Acute cytomegalovirus infection and IgM anti-GM2 antibody.
Yuki N; Tagawa Y
J Neurol Sci; 1998 Jan; 154(1):14-7. PubMed ID: 9543317
[TBL] [Abstract][Full Text] [Related]
7. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
8. Detection of serum anti-ganglioside antibodies by latex agglutination assay in Guillain-Barré syndrome: comparison with ELISA.
Irie S; Saito T; Kanazawa N; Ogino M; Ogino Y; Sakai F
Intern Med; 2003 Jun; 42(6):490-5. PubMed ID: 12857046
[TBL] [Abstract][Full Text] [Related]
9. CMV-associated axonal sensory-motor Guillain-Barré syndrome in a child: Case report and review of the literature.
Spagnoli C; Iodice A; Salerno GG; Frattini D; Bertani G; Pisani F; Fusco C
Eur J Paediatr Neurol; 2016 Jan; 20(1):168-75. PubMed ID: 26621312
[TBL] [Abstract][Full Text] [Related]
10. Guillain-Barré Syndrome in a Teenage Girl: A Severe Case With Anti-GM2 Antibodies Associated With Acute CMV Infection and Literature Review.
Silva CT; Silva S; Silva MJ; Almeida AF; Fonseca J; Melo C; Sampaio M; Sousa R
Clin Pediatr (Phila); 2020 Mar; 59(3):300-304. PubMed ID: 31888351
[No Abstract] [Full Text] [Related]
11. Detection of anti-ganglioside antibodies in Guillain-Barré syndrome and its variants by the agglutination assay.
Alaedini A; Briani C; Wirguin I; Siciliano G; D'Avino C; Latov N
J Neurol Sci; 2002 Apr; 196(1-2):41-4. PubMed ID: 11959155
[TBL] [Abstract][Full Text] [Related]
12. Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes.
Yuki N
Lancet Infect Dis; 2001 Aug; 1(1):29-37. PubMed ID: 11871407
[TBL] [Abstract][Full Text] [Related]
13. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
[TBL] [Abstract][Full Text] [Related]
14. Preceding infections and anti-ganglioside antibody profiles assessed by a dot immunoassay in 306 French Guillain-Barré syndrome patients.
Caudie C; Quittard Pinon A; Taravel D; Sivadon-Tardy V; Orlikowski D; Rozenberg F; Sharshar T; Raphaël JC; Gaillard JL
J Neurol; 2011 Nov; 258(11):1958-64. PubMed ID: 21516465
[TBL] [Abstract][Full Text] [Related]
15. Post-CMV Guillain-Barré Syndrome with Anti-GM2 Antibodies: Two Cases and a Review of the Literature.
Manaud A; Geraudie A; Viguier A; Mengelle C; Fortenfant F; Baudou E; Cheuret E
Neuropediatrics; 2022 Aug; 53(4):235-238. PubMed ID: 35716658
[TBL] [Abstract][Full Text] [Related]
16. Anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection.
Nakamura K; Irie S; Kanazawa N; Saito T; Tamai Y
Ann N Y Acad Sci; 1998 Jun; 845():423. PubMed ID: 9668386
[No Abstract] [Full Text] [Related]
17. IgM anti-GM2 antibody in a patient with Guillain-Barré syndrome subsequent to cytomegalovirus hepatitis cross reacts with N-acetylgalactosaminyl GD1a.
Tsukaguchi M; Tagawa Y; Takeuchi H; Yuki N
J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):407-8. PubMed ID: 9728970
[No Abstract] [Full Text] [Related]
18. Primary cytomegalovirus infection in patients with Guillain-Barré syndrome.
Steininger C; Seiser A; Gueler N; Puchhammer-Stöckl E; Aberle SW; Stanek G; Popow-Kraupp T
J Neuroimmunol; 2007 Feb; 183(1-2):214-9. PubMed ID: 17184845
[TBL] [Abstract][Full Text] [Related]
19. Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a.
Kaida K; Kusunoki S; Kamakura K; Motoyoshi K; Kanazawa I
J Neuroimmunol; 2001 Feb; 113(2):260-7. PubMed ID: 11164910
[TBL] [Abstract][Full Text] [Related]
20. Range of cross reactivity of anti-GM1 IgG antibody in Guillain-Barré syndrome.
Koga M; Tatsumoto M; Yuki N; Hirata K
J Neurol Neurosurg Psychiatry; 2001 Jul; 71(1):123-4. PubMed ID: 11413278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
